A study conducted by Papakostas and collaborators (2006)
evaluated the effectiveness of bupropion when used in combination
with duloxetine in a treatment-resistant MDD population,
utilizing outcome measures including the Clinical Global Impressions
(CGI) Scale to evaluate clinical improvement.